When was Magnus Medical founded?

Magnus Medical was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is Magnus Medical located?

Magnus Medical is headquartered in Burlingame, United States. It is registered at 1350 Old Bayshore Highway Suite 600 Burlingame CA 94010 USA.

How many employees does Magnus Medical have?

As of May 31, 2026, the latest employee count at Magnus Medical is 74.

Is Magnus Medical a funded company?

Magnus Medical is a funded company, having raised a total of $65.3M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 29, 2021.

When was the latest funding round of Magnus Medical?

Magnus Medical's latest funding was a $***** Series B round on Feb 07, 2025, with participation from 0 investor.

Where does Magnus Medical rank among its competitors?

Magnus Medical ranks 4th amongst 17 active competitors, of which 6 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Magnus, which secured $1.21M in Jul, 2025.

Who are the top competitors of Magnus Medical?

Magnus Medical's top competitors include NeuroStar, Flow Neuroscience and Neuronetics. Among them, Magnus secured the most recent funding round in July, 2025.

Magnus Medical - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of non invasive neuromodulation system for depression treatment. It offers SAINT which is ad, MRI guided neuromodulation system that offers a rapid acting, non invasive treatment for major depressive disorder for patients who have not responded to traditional antidepressant therapies.

Website: magnusmed.com
Social
Email ID: *****@magnusmed.com
Phone Number: +1 **********
Registered Address: 1350 Old Bayshore Highway Suite 600 Burlingame CA 94010 USA

Key Metrics

Founded Year

2017

Location

Burlingame, United States

Stage

Series B

Total Funding

$65.3M in 2 rounds

Latest Funding Round

Series B, Feb 07, 2025, $*****

Investors

JAZZ Venture Partners & 2 more

Ranked

4^th among 17 active competitors

Employee Count

74 as on May 31, 2026

Similar Companies

NeuroStar & 15 more

View Magnus Medical's full profile

Magnus Medical is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MAGNUS MEDICAL, INC CIN: 85-2402299 , United States, Active	Aug 10, 2020	-	38 (As on Dec 31, 2023)	-

Magnus Medical has raised a total funding of $65.3M over 2 rounds. Its first funding round was on Oct 29, 2021. Magnus Medical has 3 institutional investors.

Here is the list of recent funding rounds of Magnus Medical:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 07, 2025	2534206	Series B	5414308	3279714	5863018	5885939
Oct 29, 2021	7906997	Series A	4902350	2916288	JAZZ Venture Partners & 1 more	3865520

Access funding benchmarks and valuations. Sign up today!

View details of Magnus Medical's funding rounds and investors

The founders of Magnus Medical is Brandon Bentzley.

Here are the details of Magnus Medical's key team members:

Brandon Bentzley: Co-Founder of Magnus Medical and founder of 1 other company.
Contact Info: 1 email address

View details of Magnus Medical's Founder profiles and Board Members

Magnus Medical's employee count trend

Magnus Medical has 74 employees as of May 26. Here is Magnus Medical's employee count trend over the years:

Uncover Magnus Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Magnus Medical include NeuroStar, Flow Neuroscience and Neuronetics. Here is the list of Top 10 competitors of Magnus Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroStar 2003, Malvern (United States), Public	Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation	$119M	Ascension Ventures, Quaker Partners Management ... & 14 others	70/100
2nd	Flow Neuroscience 2016, Malmo (Sweden), Series A	Provider of a wearable device for stress and anxiety management	$11.9M	Khosla Ventures, HAX & 6 others	61/100
3rd	Neuronetics 2001, Malvern (United States), Series G	Transforming neurohealth with innovative, non-drug TMS therapy for mental health	$178M	Polaris Partners, Pfizer Venture Investments ... & 16 others	60/100
4th	Magnus Medical 2017, Burlingame (United States), Series B	Provider of non invasive neuromodulation system for depression treatment	$65.3M	Red Tree Venture Capital, JAZZ Venture Partners ... & 1 others	54/100
5th	Magstim 1990, Whitland (United Kingdom), Acquired	Developer of EEG, TMS, and tDCS neurotechnology solutions	$32.1M	Finance Wales, Telegraph Hill Partners & 1 others	51/100
6th	Brainsway 2003, Jerusalem (Israel), Public	Develoepr of noninvasive neurostimulation treatments for mental health disorders	-	Shavit Capital, IBI Investment House & 3 others	46/100
7th	Soterix Medical 2008, New York City (United States), Funding Raised	Neuromodulation and brain stimulation technology for neuropsychiatric and neurological disorders	-	NINDS, HHS	41/100
8th	Tonic 1991, Farum (Denmark), Unfunded	Manufacturer of transcranial magnetic stimulation (TMS) systems for research and treatment	-	-	39/100
9th	Magnus 2020, Burlingame (United States), Series C	Provider of transcranial magnetic stimulation therapy for major depressive disorder	$49M	HHS	34/100
10th	Neuroprex 2012, Santa Clara (United States), Seed	Developer of a wearable device to modulate tissue for neurological diseases	$50K	EIC Fund, Europa & 1 others	32/100